Abstract
Cardiac tumors are found in less than 1% of adult and pediatric autopsies. More than three-fourths of primary cardiac neoplasms are benign, with myxomas and rhabdomyomas being the most common cardiac tumors seen in adults and children, respectively. Primary malignant cardiac tumors are extremely rare, whereas metastatic lesions can be seen in approximately 8% of patients dying from cancer. Attempting to understand why the heart is so resistant to carcinogenesis and which fail-safe mechanisms malfunction when cardiac tumors do develop is particularly challenging considering the rarity of these tumors and the fact that when relevant clinical studies are published, they rarely focus on molecular pathogenesis. Apart from cancer cells, solid tumors are comprised of a concoction of noncancerous cells, and extracellular matrix constituents, which along with pH and oxygen levels jointly constitute the so-called tumor microenvironment (TME). In the present chapter, we explore mechanisms through which TME may influence cardiac carcinogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV (2007) Cardiac tumours in children. Orphanet J Rare Dis 2:11
Molina JE, Edwards JE, Ward HB (1990) Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardiovasc Surg 38(Suppl 2):183–191
Kamiya H, Yasuda T, Nagamine H, Sakakibara N, Nishida S, Kawasuji M et al (2001) Surgical treatment of primary cardiac tumors: 28 years’ experience in Kanazawa University Hospital. Jpn Circ J 65(4):315–319
Odim J, Reehal V, Laks H, Mehta U, Fishbein MC (2003) Surgical pathology of cardiac tumors. Two decades at an urban institution. Cardiovasc Pathol 12(5):267–270
Shi L, Wu L, Fang H, Han B, Yang J, Ma X et al (2017) Identification and clinical course of 166 pediatric cardiac tumors. Eur J Pediatr 176(2):253–260
Tazelaar HD, Locke TJ, McGregor CG (1992) Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc 67(10):957–965
Tzani A, Doulamis IP, Mylonas KS, Avgerinos DV, Nasioudis D (2017) Cardiac tumors in pediatric patients: a systematic review. World J Pediatr Congenit Heart Surg 8(5):624–632
Ying L, Lin R, Gao Z, Qi J, Zhang Z, Gu W (2016) Primary cardiac tumors in children: a center’s experience. J Cardiothorac Surg 11(1):52
Silvestri F, Bussani R, Pavletic N, Mannone T (1997) Metastases of the heart and pericardium. G Ital Cardiol 27(12):1252–1255
Longo R, Mocini D, Santini M, Giannantoni P, Carillio G, Torino F et al (2004) Unusual sites of metastatic malignancy: Case 1. Cardiac metastasis in hepatocellular carcinoma. J Clin Oncol 22(24):5012–5014
Savoia P, Fierro MT, Zaccagna A, Bernengo MG (2000) Metastatic melanoma of the heart. J Surg Oncol 75(3):203–207
Reynen K, Kockeritz U, Strasser RH (2004) Metastases to the heart. Ann Oncol Off J Eur Soc Med Oncol 15(3):375–381
Goldberg AD, Blankstein R, Padera RF (2013) Tumors metastatic to the heart. Circulation 128(16):1790–1794
Tessmer G (2018) How it feels to be swallowed by a black hole. Nature 563:592
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
Hirata E, Sahai E (2017) Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med 7(7). https://doi.org/10.1101/cshperspect.a026781
Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309–322
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Tahmasebi Birgani M, Carloni V (2017) Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy. Int J Mol Sci 18(2). https://doi.org/10.3390/ijms18020405
Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G (2013) Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol 23(6 Pt B):522–532
Sormendi S, Wielockx B (2018) Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment. Front Immunol 9:40
Netea-Maier RT, Smit JWA, Netea MG (2018) Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship. Cancer Lett 413:102–109
Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15(1):102–111
Cedervall J, Dimberg A, Olsson A-K (2015) Tumor-induced local and systemic impact on blood vessel function. Mediat Inflamm 2015:418290
Cedervall J, Zhang Y, Huang H, Zhang L, Femel J, Dimberg A et al (2015) Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res 75(13):2653–2662
Grigorian-Shamagian L, Fereydooni S, Liu W, Echavez A, Marban E (2017) Harnessing the heart’s resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents. Oncotarget 8(59):99624–99636
Tirziu D, Giordano FJ, Simons M (2010) Cell communications in the heart. Circulation 122(9):928–937
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563–572. https://doi.org/10.1038/nrc865
Kellner J, Sivajothi S, McNiece I (2015) Differential properties of human stromal cells from bone marrow, adipose, liver and cardiac tissues. Cytotherapy 17(11):1514–1523
Rossini A, Frati C, Lagrasta C, Graiani G, Scopece A, Cavalli S et al (2010) Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. Cardiovasc Res 89(3):650–660. https://doi.org/10.1093/cvr/cvq290
Gaur K, Majumdar K, Kisku N, Gondal R, Sakhuja P, Satsangi DK (2017) Primary intracardiac leiomyoma arising from cardiomyocyte progenitors at the right ventriculoseptal interface: case report with literature review. Cardiovasc Pathol 28:46–50
Qian X-J, Li X-L, Xu X, Wang X, Feng Q-T, Yang C-J (2015) Alpha-SMA-Cre-mediated excision of PDK1 reveals an essential role of PDK1 in regulating morphology of cardiomyocyte and tumor progression in tissue microenvironment. Pathol Biol (Paris) 63(2):91–100
Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136(5):839–851. Available from: http://www.sciencedirect.com/science/article/pii/S0092867409000683
Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (London, England) 379(9819):895–904
Aminzadeh MA, Tseliou E, Sun B, Cheng K, Malliaras K, Makkar RR et al (2015) Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. Eur Heart J 36(12):751–762
Chakravarty T, Makkar RR, Ascheim DD, Traverse JH, Schatz R, DeMaria A et al (2017) ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) trial: rationale and design. Cell Transplant 26(2):205–214
Tsilimigras DI, Oikonomou EK, Moris D, Schizas D, Economopoulos KP, Mylonas KS (2017) Stem cell therapy for congenital heart disease: a systematic review. Circulation 136(24):2373–2385
Ibrahim AG-E, Cheng K, Marban E (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2(5):606–619
Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L et al (2010) Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70(17):6945–6956
Polanska UM, Orimo A (2013) Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol 228(8):1651–1657
Coleman DT, Gray AL, Stephens CA, Scott ML, Cardelli JA (2016) Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation. Oncotarget 7(22):32200–32209
Fang H, Declerck YA (2013) Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res 73(16):4965–4977
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mylonas, K.S., Ziogas, I.A., Avgerinos, D.V. (2020). Microenvironment in Cardiac Tumor Development: What Lies Beyond the Event Horizon?. In: Birbrair, A. (eds) Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology, vol 1226. Springer, Cham. https://doi.org/10.1007/978-3-030-36214-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-36214-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36213-3
Online ISBN: 978-3-030-36214-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)